1. Report Introduction 2. Epidermolysis Bullosa Overview 3. Pipeline Therapeutics • An Overview of Pipeline Products for Epidermolysis Bullosa 4. Comparative Analysis 5. Products in Clinical Stage 5.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities 6. Products in Pre-Clinical and Discovery Stage 6.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities 7. Therapeutic Assessment • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type 8. Inactive Products 8.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities Appendix Report Methodology Consulting Services Disclaimer About DelveInsight

Table 1: Total Products for Epidermolysis Bullosa Table 2: Products in Clinical Stage Table 3: Products in Non-clinical Stage Table 4: Assessment by Route of Administration Table 5: Assessment by Stage and Route of Administration Table 6: Assessment by Molecule Type Table 7: Assessment by Stage and Molecule Type Table 8: Inactive Products Figure 1: Total Products for Epidermolysis Bullosa Figure 2: Products in Clinical Stage Figure 3: Products in Non-clinical Stage Figure 4: Assessment by Route of Administration Figure 5: Assessment by Stage and Route of Administration Figure 6: Assessment by Molecule Type Figure 7: Assessment by Stage and Molecule Type Figure 8: Inactive Products

Abeona Therapeutics Inc Almirall SA Amryt Pharma plc Anterogen Co Ltd Berg LLC CSL Ltd Exicure Inc Fibrocell Science Inc GlaxoSmithKline Plc Immusoft Corp InMed Pharmaceuticals Inc Karus Therapeutics Ltd Mesoblast Ltd ProQR Therapeutics NV RegeneRx Biopharmaceuticals Inc Scioderm Inc & list continues...